The (II)logic of iron reduction therapy for steatohepatitis
Paul C. Adams – 24 April 2015
Reply
Toshimi Kaido, Ahmed Hammad, Shinji Uemoto – 24 April 2015
Reply
Guangqin Xiao, Jia Shen, Lunan Yan – 24 April 2015
Myeloid cells in hepatocellular carcinoma
Shanshan Wan, Ning Kuo, Ilona Kryczek, Weiping Zou, Theodore H. Welling – 24 April 2015 – Hepatocellular carcinoma (HCC) is highly associated with inflammation. Myeloid cells, including tumor‐associated macrophages and myeloid‐derived suppressor cells, are abundant in the HCC microenvironment and are often associated with poor prognosis. Myeloid cells in HCC play a vital role in supporting tumor initiation, progression, angiogenesis, metastasis, and therapeutic resistance.
Reply
Mathieu Sertorio, Rodrigo F. Carmo, Sandrine Cabantous, Luydson Vasconcelos, Leila Beltrao Pereira, Patricia Moura, Alain Dessein – 23 April 2015
Eliminating transplant tourism in the United States as a means to decrease wait‐list mortality of US residents
David S. Goldberg, Thomas D. Schiano – 23 April 2015
Reply
Christine E. McLaren, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, James C. Barton, Paul C. Adams, Lawrie W. Powell, Lyle C. Gurrin, Grant A. Ramm, Gregory J. Anderson, Gordon D. McLaren – 23 April 2015
Perioperative changes in nutritional parameters and impact of graft size in patients undergoing adult living donor liver transplantation
Mehmet Agilli, Tolga Dogan – 23 April 2015
Presentation, diagnosis, and management of early hepatic venous outflow complications in whole cadaveric liver transplant
Shirin Elizabeth Khorsandi, Anuja Athale, Hector Vilca‐Melendez, Wayel Jassem, Andreas Prachalias, Parthi Srinivasan, Mohamed Rela, Nigel Heaton – 23 April 2015 – Early hepatic venous outflow obstruction (HVOO) can be a devastating complication leading to graft loss after liver transplantation (LT).
Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation
Neema Kaseje, Valerie McLin, Christian Toso, Antoine Poncet, Barbara E. Wildhaber – 23 April 2015 – The demand for transplantable organs far outweighs the supply. Recently, efforts have been made to increase the donor pool by adopting extended criteria for livers, including those from hypernatremic donors. Currently, there is no clear evidence that the use of organs from hypernatremic donors has detrimental effects on pediatric liver transplantation (LT) recipients.